Neuroprotective effects of phenylbutyrate against MPTP neurotoxicity

NeuroMolecular Medicine

Volumn 5, Issue 3, 2004, Pages 235-241

  Gardian, Gabriella ^a   Yang, Lichuan ^a   Cleren, Carine ^a   Calingasan, Noel Y ^a   Klivenyi, Peter ^a   Beal, M Flint ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Gene transcription; Histone acetylation; MPTP; Parkinson's disease; Phenylbutynate

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; ANTIOXIDANT; ARYLBUTYRIC ACID DERIVATIVE; CHAPERONE; HISTONE DEACETYLASE INHIBITOR; TYROSINE 3 MONOOXYGENASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; ATTENUATION; CELL SURVIVAL; CONTROLLED STUDY; DOPAMINE RELEASE; GENETIC TRANSCRIPTION; MOUSE; NERVE DEGENERATION; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; SUBSTANTIA NIGRA;

1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE; ANIMALS; BRAIN; CORPUS STRIATUM; DISEASE MODELS, ANIMAL; DOPAMINE; HISTONE DEACETYLASES; IMMUNOHISTOCHEMISTRY; MICE; NEUROPROTECTIVE AGENTS; PARKINSONIAN DISORDERS; PHENYLBUTYRATES; SUBSTANTIA NIGRA; TRANSCRIPTION, GENETIC; TREATMENT OUTCOME; TYROSINE 3-MONOOXYGENASE;

ANIMALIA;

EID: 12344291203     PISSN: 15351084     EISSN: None     Source Type: Journal    
DOI: 10.1385/NMM:5:3:235     Document Type: Article

References (26)

1. Beal M. F., Ferrante R. J., Henshaw R., et al. (1995) 3-Nitropropionic acid neurotoxicity is attenuated in copper/zinc superoxide dismutase transgenic mice. J. Neurochem. 65, 919-922.
2. Beal M. F., Matson W. R., Storey E., et al. (1992) Kynurenic acid concentrations are reduced in Huntington's disease cerebral cortex. J. Neurol. Sci. 108, 80-87.
3. Beal M. F., Matson W. R., Swartz K. J., Gamache P. H., and Bird E. D. (1990) Kynurenine pathway measurements in Huntington's disease striatum: evidence for reduced formation of kynurenic acid. J. Neurochem. 55, 1327-1339.
4. Chang J. G., Hsieh-Li H. M., Jong Y. J., Wang N. M., Tsai C. H., and Li H. (2001) Treatment of spinal muscular atrophy by sodium butyrate. Proc. Natl. Acad. Sci. USA 98, 9808-9813.
5. Corcoran L. J., Mitchison T. J., and Liu Q. (2004) A novel action of histone deacetylase inhibitors in a protein aggresome disease model. Curr. Biol. 14, 488-492.
6. Czubryt M. P., McAnally J., Fishman G. I., and Olson E. N. (2003) Regulation of peroxisome proliferator-activated receptor gamma coactivator 1 alpha (PGC-1 alpha) and mitochondrial function by MEF2 and HDAC5. Proc. Natl. Acad. Sci. USA 100, 1711-1716.
7. Ferrante R. J., Kubilus J. K., Lee J., et al. (2003) Histone deacetylase inhibition by sodium butyrate chemotherapy ameliorates the neurodegenerative phenotype in Huntington's disease mice. J. Neurosci. 23, 9418-9427.
8. Hockly E., Richon V. M., Woodman B., et al. (2003) Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor, ameliorates motor deficits in a mouse model of Huntington's disease. Proc. Natl. Acad. Sci. USA 100, 2041-2046.
9. Jeong M. R., Hashimoto R., Senatorov V. V., et al. (2003) Valproic acid, a mood stabilizer and anticonvulsant, protects rat cerebral cortical neurons from spontaneous cell death: a role of histone deacetylase inhibition. FEBS Lett. 542, 74-78.
10. Kaeberlein M., McVey M., and Guarente L. (1999) The SIR2/3/4 complex and SIR2 alone promote longevity in Saccharomyces cerevisiae by two different mechanisms. Gene Dev. 13, 2570-2580.
11. Kang H. L., Benzer S., and Min K. T. (2002) Life extension in Drosophila by feeding a drug. Proc. Natl. Acad. Sci. USA 99, 838-843.
12. Leoni F., Zaliani A., Bertolini G., et al. (2002) The anti-tumor histone deacetylase inhibitor suberoylanilide hydroxamic acid exhibits antiinflammatory properties via suppression of cytokines. Proc. Natl. Acad. Sci. USA 99, 2995-3000.
13. Maehara K., Uekawa N., and Isobe K. (2002) Effects of histone acetylation on transcriptional regulation of manganese superoxide dismutase gene. Biochem. Biophys. Res. Comm. 295, 187-192.
14. McCampbell A., Taye A. A., Whitty L., Penney E., Steffan J. S., and Fischbeck K. H. (2001) Histone deacetylase inhibitors reduce polyglutamine toxicity. Proc. Natl. Acad. Sci. USA 98, 15,179-15,184.
15. McGuinness M. C., Lu J. F., Zhang H. P., et al. (2003) Role of ALDP (ABCD1) and mitochondria in X-linked adrenoleukodystrophy. Mol. Cell Biol. 23, 744-753.
16. McKinsey T. A., Zhang C. L., and Olson E. N. (2000) Activation of myocyte enhancer factor-2 transcription factorby calcium/calmodulin-dependent protein kinase-stimulated binding of 14-3-3 to histone deactylase 5. Proc. Natl. Acad. Sci. USA 97, 14400-14405.
17. Minamiyama M., Katsuno M., Adachi H., et al. (2004) Sodium butyrate ameliorates phenotypic expression in a transgenic mouse model of spinal and bulbar muscular atrophy. Hum. Mol. Genet. 13, 1183-1192.
18. Naya F. J., Black B. L., Wu H., et al. (2002) Mitochondrial deficiency and cardiac sudden death in mice lacking the MEF2A transcription factor. Nat. Med. 8, 1303-1309.
19. Onyango P., Celic I., McCaffery M., et al. (2002) SIRT3, a human SIR2 homologue, is an NAD-dependent deacetylase localized to mitochondria. Proc. Natl. Acad. Sci. USA 99, 13653-13658.
20. Puigserver P. and Spiegelman B. M. (2003) Peroxisome proliferator- activated receptor-gamma coactivator 1 alpha (PGC-1 alpha): transcriptional coactivator and metabolic regulator. Endocr. Rev. 24, 78-90.
21. Ryu H., Lee J., Olofsson B. A., et al. (2003) Histone deacetylase inhibitors prevent oxidative neuronal death independent of expanded polyglutamine repeats via an Spl-dependent pathway. Proc. Natl. Acad. Sci. USA 100, 4281-4286.
22. Schulz J. B., Henshaw D. R., MacGarvey U., and Beal, M. F. (1996) Involvement of oxidative stress in 3-nitropropionic acid neurotoxicity. Neurochem. Int. 29, 167-171.
23. Steffan J. S., Bodai L., Pallos J., et al. (2001) Histone deacetylase inhibitors arrest polyglutamine-dependent neurodegeneration in Drosophila. Nature 413, 739-743.
24. Tissenbaum H. A. and Guarente L. (2001) Increased dosage of a sir-2 gene extends lifespan in Caenorhabditis elegans. Nature 410, 227-230.
25. Wu H., Kanatous S. B., Thurmond F. A., et al. (2002) Regulation of mitochondrial biogenesis in skeletal muscle by CaMK. Science 296, 349-352.
26. Youn H. D., Grozinger C. M., and Liu J. O. (2000) Calcium regulates transcriptional repression of myocyte enhancer factor 2 by histone deacetylase 4. J. Biol. Chem. 275, 22,563-22,567.